MSD K.K. seeks Japanese approval of Keytruda for locally advanced or metastatic urothelial cancer May 2, 2017
Lilly initiates phase I study of LY-3321367 in advanced relapsed or refractory solid tumors April 27, 2017
Tessa Therapeutics and Vyriad collaborate to create next generation of cancer immunotherapies April 26, 2017
Subgroups benefit from lefitolimod in phase II IMPULSE trial in small-cell lung cancer April 25, 2017
RSS